Tom Umbel

Mr. Umbel is Chief Executive Officer of Seno Medical Instruments, Inc. Tom Umbel brings more than 30 years of medical device and diagnostics leadership experience to Seno Medical. He has lead several start-up companies, including one through a successful acquisition. He has also managed large organizations through significant growth leading both the strategic development and M&A efforts in his previous roles.

Tom was most recently the VP of Business Development for Bioventus, a privately held ortho-biologics company in Durham, NC. Tom has led the Business Development efforts at both Bioventus and Hologic, the largest dedicated Women’s Health company in the U.S. Tom’s role in managing mergers and acquisitions helped to grow Hologic from a small single-product company with $100 million in revenue to a large diversified company with more than $2.5 billion in sales in his 15 years with the company.

Prior to Hologic, Tom was the President of Direct Radiography Corp. (DRC). He led the development and commercialization of the digital x-ray detector technology, which he ultimately sold to Hologic in 1999. This company’s technology became the core to Hologic’s market leading digital mammography system and was the engine to Hologic’s significant growth.

Prior to DRC, Tom worked at Sterling Diagnostic Imaging for 3 years and DuPont for 20 years. At those two companies, Tom held senior management positions in operations, engineering, sales and marketing.

Tom has a BS in Chemical Engineering from Grove City College.